Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Veatch

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
The Quality Letter for Healthcare Leaders|February 7, 1996
"Without question, most of us wish we'd started earlier"R Veatch
Biochemistry|July 13, 1976
Preparation and properties of O-dansyltyrosine gramicidin CW R Veatch, E R Blout
Cell|August 5, 2022
Immune checkpoint blockade provokes resident memory T cells to eliminate head and neck cancerJoshua R Veatch, Stanley R Riddell
Biochemistry|July 30, 1985
Conformation of the gramicidin A channel in phospholipid vesicles: a fluorine-19 nuclear magnetic resonance studyS Weinstein, J T Durkin, W R Veatch, et al.
Cell|July 1, 2009
Mitochondrial dysfunction leads to nuclear genome instability via an iron-sulfur cluster defectJoshua R Veatch, Michael A McMurray, Zara W Nelson, et al.
Genes & Development|September 17, 2003
Ku interacts with telomerase RNA to promote telomere addition at native and broken chromosome endsAnne E Stellwagen, Zara W Haimberger, Joshua R Veatch, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1982
Use of a fluorescent cholesterol derivative to measure lateral mobility of cholesterol in membranesM R Alecio, D E Golan, W R Veatch, et al.
Biochemistry|January 17, 1984
Lateral mobility of phospholipid and cholesterol in the human erythrocyte membrane: effects of protein-lipid interactionsD E Golan, M R Alecio, W R Veatch, et al.
The New England Journal of Medicine|December 15, 1983
The care of the terminally ill: morality and economicsR Bayer, D Callahan, J Fletcher, et al.
Journal for Immunotherapy of Cancer|December 10, 2020
Mobilization of pre-existing polyclonal T cells specific to neoantigens but not self-antigens during treatment of a patient with melanoma with bempegaldesleukin and nivolumabJoshua R Veatch, Naina Singhi, Brenda Jesernig, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
The Quality Letter for Healthcare Leaders|February 7, 1996
"Without question, most of us wish we'd started earlier"R Veatch
Biochemistry|July 13, 1976
Preparation and properties of O-dansyltyrosine gramicidin CW R Veatch, E R Blout
Cell|August 5, 2022
Immune checkpoint blockade provokes resident memory T cells to eliminate head and neck cancerJoshua R Veatch, Stanley R Riddell
Biochemistry|July 30, 1985
Conformation of the gramicidin A channel in phospholipid vesicles: a fluorine-19 nuclear magnetic resonance studyS Weinstein, J T Durkin, W R Veatch, et al.
Cell|July 1, 2009
Mitochondrial dysfunction leads to nuclear genome instability via an iron-sulfur cluster defectJoshua R Veatch, Michael A McMurray, Zara W Nelson, et al.
Genes & Development|September 17, 2003
Ku interacts with telomerase RNA to promote telomere addition at native and broken chromosome endsAnne E Stellwagen, Zara W Haimberger, Joshua R Veatch, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1982
Use of a fluorescent cholesterol derivative to measure lateral mobility of cholesterol in membranesM R Alecio, D E Golan, W R Veatch, et al.
Biochemistry|January 17, 1984
Lateral mobility of phospholipid and cholesterol in the human erythrocyte membrane: effects of protein-lipid interactionsD E Golan, M R Alecio, W R Veatch, et al.
The New England Journal of Medicine|December 15, 1983
The care of the terminally ill: morality and economicsR Bayer, D Callahan, J Fletcher, et al.
Journal for Immunotherapy of Cancer|December 10, 2020
Mobilization of pre-existing polyclonal T cells specific to neoantigens but not self-antigens during treatment of a patient with melanoma with bempegaldesleukin and nivolumabJoshua R Veatch, Naina Singhi, Brenda Jesernig, et al.
Pageof 3